<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(5)</volume><submitter>Aljuhani A</submitter><pubmed_abstract>Considering the widespread availability of certain medicines, there is still a critical need for potent anti-cancer agents. It is owing to numerous negative impacts and non-functionality of current drugs, particularly during the late stages of illness. To accomplish this, the new array of 1,2,3-triazole-benzothiazole molecular conjugates tethering hydrazone/thiosemicarbazone linkage 8a-l have been successfully synthesized &lt;i>via&lt;/i> the efficient copper-catalyzed 1,3-dipolar cycloaddition of the appropriate un/substituted benzothiazole azides 4a-c with several &lt;i>O&lt;/i>-propargylated benzylidene derivatives 7a-d. The newly established 1,2,3-triazole structural hybrids were thoroughly characterized using appropriate spectroscopic techniques (IR, &lt;sup>1&lt;/sup>H, &lt;sup>13&lt;/sup>C-NMR &amp; CHN analys</pubmed_abstract><journal>RSC advances</journal><pagination>3570-3591</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11792500</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer.</pubmed_title><pmcid>PMC11792500</pmcid><pubmed_authors>Aouad MR</pubmed_authors><pubmed_authors>Rezki N</pubmed_authors><pubmed_authors>Alsehli M</pubmed_authors><pubmed_authors>Bardaweel SK</pubmed_authors><pubmed_authors>Aljuhani A</pubmed_authors><pubmed_authors>Darwish KM</pubmed_authors><pubmed_authors>Nafie MS</pubmed_authors><pubmed_authors>Albujuq NR</pubmed_authors><pubmed_authors>Alraqa SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer.</name><description>Considering the widespread availability of certain medicines, there is still a critical need for potent anti-cancer agents. It is owing to numerous negative impacts and non-functionality of current drugs, particularly during the late stages of illness. To accomplish this, the new array of 1,2,3-triazole-benzothiazole molecular conjugates tethering hydrazone/thiosemicarbazone linkage 8a-l have been successfully synthesized &lt;i>via&lt;/i> the efficient copper-catalyzed 1,3-dipolar cycloaddition of the appropriate un/substituted benzothiazole azides 4a-c with several &lt;i>O&lt;/i>-propargylated benzylidene derivatives 7a-d. The newly established 1,2,3-triazole structural hybrids were thoroughly characterized using appropriate spectroscopic techniques (IR, &lt;sup>1&lt;/sup>H, &lt;sup>13&lt;/sup>C-NMR &amp; CHN analys</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T02:00:36.102Z</modification><creation>2025-04-06T22:27:08.649Z</creation></dates><accession>S-EPMC11792500</accession><cross_references><pubmed>39906636</pubmed><doi>10.1039/d4ra07540d</doi></cross_references></HashMap>